Nextech Invest

Latest statistics and disclosures from Nextech Invest's latest quarterly 13F-HR filing:

Tip: Access up to 7 years of quarterly data

Positions held by Nextech Invest consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Nextech Invest

Nextech Invest holds 11 positions in its portfolio as reported in the December 2023 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Revolution Medicines (RVMD) 33.6 $181M +30% 6.3M 28.68
 View chart
Arvinas Ord (ARVN) 13.0 $70M +490% 1.7M 41.16
 View chart
Cargo Therapeutics (CRGX) 11.4 $61M NEW 2.6M 23.15
 View chart
Tango Therapeutics (TNGX) 10.2 $55M 5.5M 9.90
 View chart
Ambrx Biopharma 8.3 $45M NEW 3.1M 14.24
 View chart
Oric Pharmaceuticals (ORIC) 7.3 $39M 4.3M 9.20
 View chart
Tyra Biosciences (TYRA) 6.5 $35M 2.5M 13.85
 View chart
Relay Therapeutics (RLAY) 2.8 $15M +12% 1.3M 11.01
 View chart
Mersana Therapeutics (MRSN) 2.6 $14M NEW 6.0M 2.32
 View chart
Cullinan Oncology (CGEM) 2.3 $12M 1.2M 10.19
 View chart
Silverback Therapeutics (SPRY) 1.9 $11M 1.9M 5.48
 View chart

Past Filings by Nextech Invest

SEC 13F filings are viewable for Nextech Invest going back to 2021